UniSa - IRIS Institutional Research Information System

PAPACCIO, Federica
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.197
NA - Nord America 1.986
EU - Europa 912
SA - Sud America 251
Continente sconosciuto - Info sul continente non disponibili 164
AF - Africa 30
OC - Oceania 5
Totale 7.545
Salva come PNG Salva come JPEG
Nazione #
HK - Hong Kong 3.136
US - Stati Uniti d'America 1.904
IT - Italia 526
SG - Singapore 506
BR - Brasile 185
CN - Cina 136
RU - Federazione Russa 130
VN - Vietnam 127
BD - Bangladesh 104
FR - Francia 64
KR - Corea 53
DE - Germania 41
CA - Canada 38
GB - Regno Unito 32
IE - Irlanda 31
IN - India 26
AR - Argentina 24
NL - Olanda 24
MX - Messico 17
JP - Giappone 16
IQ - Iraq 15
TR - Turchia 13
CO - Colombia 12
ID - Indonesia 12
UA - Ucraina 12
AT - Austria 9
ES - Italia 8
UZ - Uzbekistan 8
VE - Venezuela 8
ZA - Sudafrica 7
BE - Belgio 6
PK - Pakistan 6
EC - Ecuador 5
FI - Finlandia 5
JM - Giamaica 5
KE - Kenya 5
PL - Polonia 5
BO - Bolivia 4
DZ - Algeria 4
EE - Estonia 4
GE - Georgia 4
JO - Giordania 4
MA - Marocco 4
MY - Malesia 4
PH - Filippine 4
RO - Romania 4
AU - Australia 3
AZ - Azerbaigian 3
CL - Cile 3
CR - Costa Rica 3
HN - Honduras 3
NP - Nepal 3
PE - Perù 3
SE - Svezia 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
UY - Uruguay 3
BH - Bahrain 2
CZ - Repubblica Ceca 2
EG - Egitto 2
GP - Guadalupe 2
GT - Guatemala 2
HU - Ungheria 2
LK - Sri Lanka 2
NI - Nicaragua 2
PA - Panama 2
PY - Paraguay 2
SA - Arabia Saudita 2
SV - El Salvador 2
TH - Thailandia 2
AM - Armenia 1
AO - Angola 1
BW - Botswana 1
CI - Costa d'Avorio 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GA - Gabon 1
GY - Guiana 1
IL - Israele 1
KH - Cambogia 1
KI - Kiribati 1
KZ - Kazakistan 1
LB - Libano 1
ML - Mali 1
MQ - Martinica 1
MR - Mauritania 1
NA - Namibia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PT - Portogallo 1
RS - Serbia 1
SR - Suriname 1
VI - Stati Uniti Isole Vergini 1
Totale 7.382
Salva come PNG Salva come JPEG
Città #
Hong Kong 3.135
San Jose 331
Milan 246
Singapore 243
Ashburn 158
Dallas 149
Council Bluffs 146
Chandler 128
Princeton 95
Rome 65
Lauterbourg 61
Moscow 54
Ho Chi Minh City 47
The Dalles 47
New York 41
Santa Clara 36
Los Angeles 32
Hanoi 30
Dublin 29
Beijing 27
Andover 24
Figino 24
Redwood City 23
Naples 22
Phoenix 22
Wilmington 18
Chicago 16
Tokyo 16
Amsterdam 15
Ann Arbor 15
Frankfurt am Main 13
São Paulo 13
Turin 13
Buffalo 12
Nuremberg 11
Seattle 11
Toronto 11
Washington 11
Charlotte 10
Da Nang 10
San Francisco 10
Atlanta 8
Seoul 8
Tashkent 8
Baghdad 7
Brooklyn 7
Curitiba 7
Dhaka 7
Memphis 7
Montreal 7
Boston 6
Denver 6
Istanbul 6
Johannesburg 6
Miami 6
Newark 6
Sarno 6
Vienna 6
Brasília 5
Caracas 5
Houston 5
Jacksonville 5
Medellín 5
Mexico City 5
Munich 5
Taranto 5
Amman 4
Campinas 4
Cleveland 4
New Delhi 4
Orem 4
Poggiomarino 4
Springfield 4
Warsaw 4
Aprilia 3
Baku 3
Belo Horizonte 3
Bogotá 3
Bryan 3
Chennai 3
Cincinnati 3
Cochabamba 3
Columbia 3
Columbus 3
Costa Mesa 3
Duncan 3
Edinburgh 3
Genoa 3
González Catán 3
Haiphong 3
Hangzhou 3
Kuala Lumpur 3
Las Vegas 3
London 3
Mar del Plata 3
Mumbai 3
Nairobi 3
Nha Trang 3
North Bergen 3
Norwalk 3
Totale 5.684
Salva come PNG Salva come JPEG
Nome #
Mitochondrial transfer from Adipose stem cells to breast cancer cells drives multi-drug resistance 886
Metformin increases antitumor activity of MEK inhibitors through GLI1 downregulation in LKB1 positive human NSCLC cancer cells 724
Adipose Stem Cells and Their Interplay with Cancer Cells and Mitochondrial Reservoir: A New Promising Target 494
The role of chemotherapy in localized and locally advanced rectal cancer: A systematic revision 426
DNA-PK inhibition sustains the antitumor innate immune response in small cell lung cancer 359
Pulmonary Large-Cell Neuroendocrine Carcinoma: From Epidemiology to Therapy 291
Combined Therapeutic Strategies Based on the Inhibition of Non-Oncogene Addiction to Improve Tumor Response in EGFR- and KRAS-Mutant Non-Small-Cell Lung Cancer 227
Anti-PD1 therapy effects on T cell repertoire and functions in patients with NSCLC cancer: a preliminary study to identify biomarkers of efficacy 144
Role of the Hedgehog pathway in preventing occurrence of resistance to first, second, third generation EGFR-TKIs in first line therapy of NSCLC models with EGFR activating mutations 139
A multicenter, open-label phase II study of metformin with erlotinib in second-line therapy of stage IV non-small-cell lung cancer patients: treatment rationale and protocol dynamics of the METAL trial 134
Decoding chromosomal instability insights in CRC by integrating omics and patient-derived organoids 125
"Proteotranscriptomic analysis of advanced colorectal cancer patient derived organoids for drug sensitivity prediction" 104
Detection of postoperative plasma circulating tumour DNA and lack of CDX2 expression as markers of recurrence in patients with localised colon cancer 103
Implication of the Hedgehog pathway in hepatocellular carcinoma 96
PBMCs as Tool for Identification of Novel Immunotherapy Biomarkers in Lung Cancer 93
Concise Review: Cancer Cells, Cancer Stem Cells, and Mesenchymal Stem Cells: Influence in Cancer Development 90
A new inhibitor of glucose-6-phosphate dehydrogenase blocks pentose phosphate pathway and suppresses malignant proliferation and metastasis in vivo 86
Glucose-6-phosphate dehydrogenase blockade potentiates tyrosine kinase inhibitor effect on breast cancer cells through autophagy perturbation 81
HDAC2 depletion promotes osteosarcoma's stemness both in vitro and in vivo: a study on a putative new target for CSCs directed therapy 81
MiR-423-5p prevents MALAT1-mediated proliferation and metastasis in prostate cancer 80
Precision Medicine to Treat Advanced Gastroesophageal Adenocarcinoma: A Work in Progress 79
Ex vivo lung cancer spheroids resemble treatment response of a patient with NSCLC to chemotherapy and immunotherapy: Case report and translational study 78
HGF/MET and the Immune System: Relevance for Cancer Immunotherapy 76
Efficacy of osimertinib in combination with Hedgehog pathway inhibitors in reverting T790M-mediated resistence 75
Cancer stem cells in solid tumors: an overview and new approaches for their isolation and characterization 75
Molecular profiling of advanced solid tumours. The impact of experimental molecular-matched therapies on cancer patient outcomes in early-phase trials: the MAST study 75
Novel applications of liquid Biopsy: Comprehensive methodology for circulating biomarker exploration in peripheral blood 73
Human primary bone sarcomas contain CD133+ cancer stem cells displaying high tumorigenicity in vivo 72
Pharmacological targeting of the ephrin receptor kinase signalling by GLPG1790 in vitro and in vivo reverts oncophenotype, induces myogenic differentiation and radiosensitizes embryonal rhabdomyosarcoma cells 71
Circulating cancer stem cells: an interesting niche to explore 70
Results of the safety run-in part of the METAL (METformin in Advanced Lung cancer) study: a multicentre, open-label phase I-II study of metformin with erlotinib in second-line therapy of patients with stage IV non-small-cell lung cancer 70
Increased fucosylation has a pivotal role in invasive and metastatic properties of head and neck cancer stem cells 70
NK cell receptors in anti-tumor and healthy tissue protection: Mechanisms and therapeutic advances 68
Prognostic Nutritional Index as an independent prognostic factor in locoregionally advanced squamous cell head and neck cancer 68
How organoids can improve personalized treatment in patients with gastro-esophageal tumors 67
In the literature: August 2018 66
Neoadjuvant Chemotherapy in Locally Advanced Rectal Cancer 66
Insulitis in Human Type 1 Diabetic Pancreas: From Stem Cell Grafting to Islet Organoids for a Successful Cell-Based Therapy 65
SMO Gene Amplification and Activation of the Hedgehog Pathway as Novel Mechanisms of Resistance to Anti-Epidermal Growth Factor Receptor Drugs in Human Lung Cancer 64
ITGB1 and DDR activation as novel mediators in acquired resistance to osimertinib and MEK inhibitors in EGFR-mutant NSCLC 62
Stemness markers of osteosarcoma 60
Development of a living organoid biobank derived from colorectal cancer patients: Towards personalized medicine 58
ZNF518B as a transcriptional factor involved in colorectal cancer progression through the epithelial to mesenchymal transition 57
CNAs concordance between CRC-PDOs and the original tissue reveals relevant oncogenic pathways alterations 57
Urtica dioica L. inhibits proliferation and enhances cisplatin cytotoxicity in NSCLC cells via Endoplasmic Reticulum-stress mediated apoptosis 56
Efficacy of second and third generation EGFR tyrosine kinase inhibitors, alone or in combination, in T790M-mediated resistance 55
Prognostic nutritional index (PNI) is an independent prognostic factor in locoregionally advanced squamous cell head and neck cancer (LAHNSCC) 55
Patient-derived organoids as a tool for modelling localized colorectal cancer 54
Effect of MEK inhibition on PDL1 and and on cytokinesproduction profilein NSCLC cell lines and in human lymphocites 53
Mutation tracking in circulating tumour DNA (ctDNA) detects minimal residual disease (MRD) in patients with localized colorectal cancer (CRC) and identifies those at high risk of recurrence regardless of stage, lack of CDX2 expression and CMS subtype 52
Synergistic effects of oncogene inhibition and pyruvate dehydrogenase kinase blockade in resistant NSCLC cells 51
Effect of MEK inhibition on PD-L1 and MCH-1 expression and on cytokines production profile in NSCLC cells and in human lymphocites 51
A novel ImmunoScore, based on clinical and blood biomarkers, as prognostic model for immunotherapy in NSCLC 51
3D patient-derived gastric cancer organoids as a tool for functional precision medicine for gastric cancer patients 51
The landscape of combining immune checkpoint inhibitors with novel Therapies: Secret alliances against breast cancer 50
Metastatic colorectal cancer derived organoids recapitulate genomic profile and treatment response of the original tumor 50
An integrated analysis of gene expression profile and chromosomal aberrations highlighted the oxidative stress role in anti-HER2 drug-resistant gastric cancer models 49
Anti-PD1 therapy effects on T cell repertoire and functions in patients with NSLC cancer: a preliminary study to identify biomarkers of efficacy 47
Antitumoral efficacy of dual blockade of EGFR signaling by osimertinib in combination with selumetinib or cetuximab in activated EGFR human NSCLC tumor models 45
Efficacy of sequential treatment with first, second and third generation EGFR inhibitors and role of Hedgehog pathway in the acquisition of resistance in in vivo NSCLC models 44
Role of HGF-MET Signaling in Primary and Acquired Resistance to Targeted Therapies in Cancer. 44
Will Organoids Fill the Gap towards Functional Precision Medicine? 43
New insights from KISS activity: a prognostic biomarker in malignant pleural mesothelioma 42
Reversion of mesenchymal behaviour by AZD9291 (osimertinib) in EGFR mutant NSCLC cell lines resistant to first generation EGFR tyrosine kinase inhibitors 37
Met/Axl system as a dual target in the mesothelioma pathway and invasiveness 37
Results of safety run-in part in Metal (METformin in Advanced Lung cancer) trial 35
Synergistic effect of vismodegib and cisplatin in NSCLC models via autophagy 32
Comparative analysis of patient-derived organoids and patient-derived xenografts as avatar models for predicting response to anti-cancer therapy 26
RAS Inhibitors: Changing the Paradigm from the Undruggable 15
Preface 15
Totale 7.545
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.116
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.116
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022122 0 0 0 0 1 0 0 10 26 0 16 69
2022/2023370 26 0 6 42 46 72 6 52 83 2 30 5
2023/2024202 7 14 10 4 10 34 4 8 28 2 9 72
2024/2025630 8 24 37 17 27 76 107 34 95 40 72 93
2025/20265.324 841 1.388 1.215 79 257 94 481 104 132 247 97 389
2026/2027799 215 73 240 271 0 0 0 0 0 0 0 0
Totale 7.545